ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,567.19
1.06%
US Tech 100
19,824.00
0.93%
Dow Jones
39,375.87
0.17%
Brent Oil
86.775
-0.64%
Bitcoin
56,738.43
-0.42%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. AnaptysBio Inc (ANAB)

  7. AnaptysBio Inc (ANAB) News

ANAB

AnaptysBio (ANAB)

AnaptysBio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ANAB
DateTimeSourceHeadlineSymbolCompany
03/25/20205:02PMPR Newswire (US)Shareholder Alert: Bernstein Litowitz Berger & Grossmann LLP Announces the Filing of Securities Class Action Lawsuit Against ...NASDAQ:ANABAnaptysBio Inc
03/10/20205:03PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANABAnaptysBio Inc
03/09/20204:06PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ANABAnaptysBio Inc
03/02/20209:01AMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ANABAnaptysBio Inc
03/02/20208:58AMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:ANABAnaptysBio Inc
03/02/20208:50AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ANABAnaptysBio Inc
03/02/20208:45AMGlobeNewswire Inc.AnaptysBio Announces Fourth Quarter and Full Year 2019 Financial Results and Provides Pipeline UpdatesNASDAQ:ANABAnaptysBio Inc
02/25/20204:00PMGlobeNewswire Inc.AnaptysBio to Present at The Cowen and Company 40th Annual Health Care ConferenceNASDAQ:ANABAnaptysBio Inc
02/14/20202:15PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ANABAnaptysBio Inc
02/13/20205:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANABAnaptysBio Inc
02/13/20205:11PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANABAnaptysBio Inc
02/13/20205:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANABAnaptysBio Inc
02/13/20205:09PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANABAnaptysBio Inc
02/13/20205:08PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANABAnaptysBio Inc
02/13/20205:06PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANABAnaptysBio Inc
02/13/20202:59PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ANABAnaptysBio Inc
02/13/20208:10AMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ANABAnaptysBio Inc
02/12/20204:27PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ANABAnaptysBio Inc
02/12/20209:28AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ANABAnaptysBio Inc
01/08/20204:00PMGlobeNewswire Inc.AnaptysBio to Present at J.P. Morgan Annual Healthcare ConferenceNASDAQ:ANABAnaptysBio Inc
11/08/20198:09AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ANABAnaptysBio Inc
11/08/20198:06AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ANABAnaptysBio Inc
11/08/20198:05AMGlobeNewswire Inc.AnaptysBio Announces Third Quarter 2019 Financial Results and Provides Pipeline UpdatesNASDAQ:ANABAnaptysBio Inc
11/08/20198:00AMGlobeNewswire Inc.AnaptysBio Reports Etokimab ATLAS Phase 2b Clinical Trial in Moderate-to-Severe Atopic Dermatitis Fails to Meet Primary Endpo...NASDAQ:ANABAnaptysBio Inc
09/30/20194:19PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ANABAnaptysBio Inc
09/30/20194:15PMGlobeNewswire Inc.AnaptysBio Reports Positive Topline Data from Interim Analysis of GALLOP Phase 2 Clinical Trial of ANB019 Monotherapy in Mode...NASDAQ:ANABAnaptysBio Inc
09/27/20196:30AMGlobeNewswire Inc.AnaptysBio to Present at the Cantor Fitzgerald Global Healthcare ConferenceNASDAQ:ANABAnaptysBio Inc
09/26/20195:52PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANABAnaptysBio Inc
09/26/20195:51PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ANABAnaptysBio Inc
09/25/20194:16PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ANABAnaptysBio Inc
 Showing the most relevant articles for your search:NASDAQ:ANAB

Your Recent History

USOTC
BLLB
Bell Buckle (PK)
NASDAQ
NVDA
NVIDIA
USOTC
RSPI
RespireRx Pharmaceuticals (PK)
COIN
SHIBUSD
SHIBA INU
USOTC
SPZI
Spooz (PK)
USOTC
ERHE
ERHC Energy (CE)
AMEX
SPY
SPDR S&P 500
NASDAQ
TSLA
Tesla
USOTC
IGPK
Intergrated Cannabis Sol... (PK)
USOTC
CYDY
CytoDyn (QB)
USOTC
ENZC
Enzolytics (PK)
NASDAQ
AVXL
Anavex Life Sciences
USOTC
BLEG
Branded Legacy (PK)
USOTC
PSRU
Valiant Eagle (PK)
USOTC
GTVH
Golden Triangle Ventures (PK)
USOTC
SMCE
SMC Entertainment (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved